Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: J Pharmacokinet Pharmacodyn. 2012 Aug 30;39(5):577–590. doi: 10.1007/s10928-012-9269-x

Table 1.

Parameter estimates for intracellular-signaling tumor-regression model

Parameter symbol (Units) Definition Population mean (%RSE) IIV standard deviation as CV % (%RSE)
kinUp,Dlmn (USU/(ng/ml)/day) Production constant of dulanermin Upstream Signal 0.0944 (8.96) 36.2 (18.6)
koutUp, Dlmn (1/day) Turnover rate constant of dulanermin Upstream Signal 8.45 (6.73) 30.7 (19.8)
kinUp,Cmab (USU/(ng/ml)/day) Production constant of conatumumab Upstream Signal 0.00543 (4.86) 45.8 (9.82)
koutUp,Cmab (1/day) Turnover rate constant of conatumumab Upstream Signal 11.9 (9.38) 34.8 (20.9)
kinApop,UpSig (ASU/USU/day) Production constant of Apoptosis Signal due to Upstream Signal 0.0253 (11.1) 34.1 (28.4)
koutApop (1/day) Turnover rate constant of Apoptosis Signal 1.62 (8.63) 38.9 (17.5)
kDeath (1/ASU/day) Rate constant for tumor cell loss due to Apoptosis Signal 0.514 (11.3) 32.9 (32.2)
kG (1/day) Tumor net growth rate constant 0.124 (3.14) 47.2 (5.80)
TVSS (mm3) Steady-state (maximum) tumor volume 4890 (10.9) 28.0 (28.4)
TV(0) (mm3) Initial tumor volume 275 (2.59) 36.0 (3.74)
Proportional Error Variance 0.326
NLL 23492
AIC 47115

% RSE Relative standard error of estimate presented as a percentage, ASU Apoptosis Signal unit, USU Upstream Signal unit, CV% coefficient of variation, IIV inter-individual variability, NLL negative log likelihood, AIC Akaike’s information criterion